Amphastar Pharmaceuticals Inc
AMPH21.110USD
-0.100-0.47%
交易中 （美東）報價延遲15分鐘
1.01B總市值
7.11本益比TTM
關於 Amphastar Pharmaceuticals Inc 公司
Amphastar Pharmaceuticals, Inc. 是一家生物製藥公司，主要專注於開發、製造、營銷和銷售具有技術挑戰性的仿製藥和注射劑、吸入劑和鼻內劑產品。此外，該公司還銷售胰島素 API 產品。其大部分成品用於醫院或緊急護理臨牀環境，主要通過集團採購組織和藥品批發商簽約和分銷。其部門包括成品藥品和 API 產品。成品藥品部門製造、營銷和分銷 Primatene MIST、腎上腺素、胰高血糖素、植物萘醌、利多卡因、依諾肝素、納洛酮以及其他各種重症和非重症護理藥物。API 部門爲外部客戶和內部產品開發製造和分銷 RHI API 和豬胰島素 API。其產品線有 20 多種候選產品，包括仿製藥 ANDA、生物仿製藥等。
公司簡介
公司代碼AMPH
公司名稱Amphastar Pharmaceuticals Inc
上市日期Jun 25, 2014
CEODr. Yongfeng (Jack) Zhang, Ph.D.
員工數量2028
證券類型Ordinary Share
年結日Jun 25
公司地址11570 6th St
城市RANCHO CUCAMONGA
上市交易所NASDAQ Global Select Consolidated
國家United States of America
郵編91730
電話19099809484
網址https://amphastar.com/
公司代碼AMPH
上市日期Jun 25, 2014
CEODr. Yongfeng (Jack) Zhang, Ph.D.
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Mr. Rong Zhou
Mr. Rong Zhou
Senior Executive Vice President of Production Center, Executive Vice President of Scientific Affairs, President of Amphastar Nanjing Pharmaceuticals, Co., Ltd.
Senior Executive Vice President of Production Center, Executive Vice President of Scientific Affairs, President of Amphastar Nanjing Pharmaceuticals, Co., Ltd.
197.10K
+5.69%
Dr. Howard S. Lee, Ph.D.
Dr. Howard S. Lee, Ph.D.
Independent Director
Independent Director
148.90K
+2.90%
Mr. Floyd F. Petersen
Mr. Floyd F. Petersen
Independent Director
Independent Director
74.45K
-0.67%
Mr. William J. Peters
Mr. William J. Peters
Chief Financial Officer, Executive Vice President - Finance, Treasurer, President of International Medication Systems Limited, Director
Chief Financial Officer, Executive Vice President - Finance, Treasurer, President of International Medication Systems Limited, Director
55.44K
-0.49%
Mr. Richard K. Prins
Mr. Richard K. Prins
Lead Independent Director
Lead Independent Director
32.11K
+18.98%
Ms. Gayle Deflin
Ms. Gayle Deflin
Independent Director
Independent Director
7.84K
+188.59%
Mr. Jacob Liawatidewi
Mr. Jacob Liawatidewi
Executive Vice President of Sales and Marketing, Corporate Administration Center, President of Amphastar France Pharmaceuticals, S.A.S, Company Secretary, Director
Executive Vice President of Sales and Marketing, Corporate Administration Center, President of Amphastar France Pharmaceuticals, S.A.S, Company Secretary, Director
--
--
Mr. Dan Dischner
Mr. Dan Dischner
Vice President - Corporate Communications
Vice President - Corporate Communications
--
--
Ms. Diane G. Gerst
Ms. Diane G. Gerst
Independent Director
Independent Director
--
--
Mr. David Gaugh
Mr. David Gaugh
Director
Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Rong Zhou
Mr. Rong Zhou
Senior Executive Vice President of Production Center, Executive Vice President of Scientific Affairs, President of Amphastar Nanjing Pharmaceuticals, Co., Ltd.
Senior Executive Vice President of Production Center, Executive Vice President of Scientific Affairs, President of Amphastar Nanjing Pharmaceuticals, Co., Ltd.
197.10K
+5.69%
Dr. Howard S. Lee, Ph.D.
Dr. Howard S. Lee, Ph.D.
Independent Director
Independent Director
148.90K
+2.90%
Mr. Floyd F. Petersen
Mr. Floyd F. Petersen
Independent Director
Independent Director
74.45K
-0.67%
Mr. William J. Peters
Mr. William J. Peters
Chief Financial Officer, Executive Vice President - Finance, Treasurer, President of International Medication Systems Limited, Director
Chief Financial Officer, Executive Vice President - Finance, Treasurer, President of International Medication Systems Limited, Director
55.44K
-0.49%
Mr. Richard K. Prins
Mr. Richard K. Prins
Lead Independent Director
Lead Independent Director
32.11K
+18.98%
Ms. Gayle Deflin
Ms. Gayle Deflin
Independent Director
Independent Director
7.84K
+188.59%
收入明細
單位: USD更新時間: 7月6日 週日
單位: USD更新時間: 7月6日 週日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
暫無數據
地區USD
名稱
營收
佔比
United States
162.59M
95.35%
France
7.86M
4.61%
China
81.00K
0.05%
業務
地區
暫無數據
股東統計
更新時間: 5月17日 週六
更新時間: 5月17日 週六
持股股東
股東類型
持股股東
持股股東
佔比
Applied Physics & Chemistry Laboratories, Inc.
14.48%
BlackRock Institutional Trust Company, N.A.
11.72%
Zhang (Jack Yongfeng)
5.57%
The Vanguard Group, Inc.
5.12%
TD Asset Management Inc.
4.32%
Other
58.79%
持股股東
持股股東
佔比
Applied Physics & Chemistry Laboratories, Inc.
14.48%
BlackRock Institutional Trust Company, N.A.
11.72%
Zhang (Jack Yongfeng)
5.57%
The Vanguard Group, Inc.
5.12%
TD Asset Management Inc.
4.32%
Other
58.79%
股東類型
持股股東
佔比
Investment Advisor
41.31%
Investment Advisor/Hedge Fund
22.63%
Corporation
14.48%
Individual Investor
9.20%
Hedge Fund
6.05%
Research Firm
1.44%
Pension Fund
0.97%
Bank and Trust
0.32%
Sovereign Wealth Fund
0.11%
Other
3.48%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
601
45.52M
96.57%
-3.82M
2025Q1
611
45.81M
97.08%
-3.30M
2024Q4
605
46.57M
97.74%
-2.04M
2024Q3
587
46.65M
96.28%
-609.11K
2024Q2
577
45.56M
93.11%
-1.23M
2024Q1
560
44.76M
91.63%
-1.31M
2023Q4
542
44.44M
92.40%
-767.71K
2023Q3
510
43.50M
90.64%
-1.16M
2023Q2
483
43.02M
88.37%
-388.11K
2023Q1
456
42.07M
87.29%
-710.60K
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Applied Physics & Chemistry Laboratories, Inc.
6.83M
14.48%
--
--
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
5.52M
11.72%
-66.62K
-1.19%
Mar 31, 2025
Zhang (Jack Yongfeng)
2.62M
5.57%
+200.00K
+8.25%
Jun 13, 2025
The Vanguard Group, Inc.
2.41M
5.12%
-291.72K
-10.78%
Mar 31, 2025
TD Asset Management Inc.
2.21M
4.69%
+371.86K
+20.21%
Mar 31, 2025
State Street Global Advisors (US)
1.60M
3.4%
+8.50K
+0.53%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
1.36M
2.88%
+157.77K
+13.16%
Mar 31, 2025
Fuller & Thaler Asset Management Inc.
1.26M
2.68%
+130.67K
+11.53%
Mar 31, 2025
Epoch Investment Partners, Inc.
1.26M
2.68%
+160.03K
+14.53%
Mar 31, 2025
Boston Trust Walden Company
1.22M
2.58%
+236.70K
+24.18%
Mar 31, 2025
查看更多
持股ETF
更新時間: 8月2日 週六
更新時間: 8月2日 週六
機構名稱
佔比
Invesco Pharmaceuticals ETF
2.43%
SPDR S&P Pharmaceuticals ETF
1.92%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
1.36%
Invesco S&P SmallCap 600 GARP ETF
0.99%
Acquirers Small and Micro Deep Value ETF
0.92%
Invesco S&P SmallCap Health Care ETF
0.6%
iShares U.S. Pharmaceuticals ETF
0.42%
Distillate Small/Mid Cash Flow ETF
0.42%
First Trust Small Cap Value AlphaDEX Fund
0.41%
VictoryShares Small Cap Free Cash Flow ETF
0.39%
查看更多
Invesco Pharmaceuticals ETF
佔比2.43%
SPDR S&P Pharmaceuticals ETF
佔比1.92%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
佔比1.36%
Invesco S&P SmallCap 600 GARP ETF
佔比0.99%
Acquirers Small and Micro Deep Value ETF
佔比0.92%
Invesco S&P SmallCap Health Care ETF
佔比0.6%
iShares U.S. Pharmaceuticals ETF
佔比0.42%
Distillate Small/Mid Cash Flow ETF
佔比0.42%
First Trust Small Cap Value AlphaDEX Fund
佔比0.41%
VictoryShares Small Cap Free Cash Flow ETF
佔比0.39%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
